These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 21073319

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Biodegradable hybrid polymeric membranes for ocular drug delivery.
    Jain D, Carvalho E, Banerjee R.
    Acta Biomater; 2010 Apr; 6(4):1370-9. PubMed ID: 19900594
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preparation and characterization of polyvinyl alcohol-gelatin hydrogel membranes for biomedical applications.
    Pal K, Banthia AK, Majumdar DK.
    AAPS PharmSciTech; 2007 Mar 16; 8(1):21. PubMed ID: 17408220
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Controlled transscleral drug delivery formulations to the eye: establishing new concepts and paradigms in ocular anti-inflammatory therapeutics and antibacterial prophylaxis.
    Paganelli F, Cardillo JA, Dare AR, Melo LA, Lucena DR, Silva AA, Oliveira AG, Pizzolitto AC, Lavinsky D, Skaf M, Souza-Filho AA, Höfling-Lima AL, Nguyen QD, Kuppermann BD, Herrero-Vanrell R, Belfort R, Brazilian Ocular Pharmacology and Pharmaceutical Technology Research Group.
    Expert Opin Drug Deliv; 2010 Aug 16; 7(8):955-65. PubMed ID: 20645672
    [Abstract] [Full Text] [Related]

  • 9. Properties and active substance release kinetics from gelatin-alginate matrices.
    Pluta J, Haznar D.
    Polim Med; 2006 Aug 16; 36(3):55-69. PubMed ID: 17190292
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. PVA/anionic collagen membranes as drug carriers of ciprofloxacin hydrochloride with sustained antibacterial activity and potential use in the treatment of ulcerative keratitis.
    Daza JHU, Righetto GM, Chaud MV, da Conceição Amaro Martins V, Lopes Baratella da Cunha Camargo I, Maria de Guzzi Plepis A.
    J Biomater Appl; 2020 Sep 16; 35(3):301-312. PubMed ID: 32571170
    [Abstract] [Full Text] [Related]

  • 13. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
    Shaheen SM, Takezoe K, Yamaura K.
    Biomed Mater Eng; 2004 Sep 16; 14(4):371-82. PubMed ID: 15472386
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multicomposite ultrathin capsules for sustained ocular delivery of ciprofloxacin hydrochloride.
    Bhadra D, Gupta G, Bhadra S, Umamaheshwari RB, Jain N.
    J Pharm Pharm Sci; 2004 Jul 16; 7(2):241-51. PubMed ID: 15367382
    [Abstract] [Full Text] [Related]

  • 16. Ocular inserts for controlled delivery of pefloxacin mesylate: preparation and evaluation.
    Sultana Y, Aqil M, Ali A.
    Acta Pharm; 2005 Sep 16; 55(3):305-14. PubMed ID: 16375841
    [Abstract] [Full Text] [Related]

  • 17. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Guzek JP, Chacko D, Kettering JD, Wessels IF, Aprecio RM.
    Cornea; 1994 Nov 16; 13(6):500-4. PubMed ID: 7842708
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Systematic evolution of a porous hydroxyapatite-poly(vinylalcohol)-gelatin composite.
    Nayar S, Sinha A.
    Colloids Surf B Biointerfaces; 2004 May 01; 35(1):29-32. PubMed ID: 15261052
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.